PINDOLOL - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for pindolol and what is the scope of patent protection?

Pindolol is the generic ingredient in two branded drugs marketed by Ani Pharms, Aurobindo Pharma Usa, Bayshore Pharms Llc, Cosette, Mylan Pharms Inc, Nostrum Labs, Nostrum Labs Inc, Purepac Pharm, Sun Pharm Industries, Watson Labs, Zydus Pharms, and Novartis, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for pindolol. Nine suppliers are listed for this compound.

Summary for PINDOLOL

US Patents:	0
Tradenames:	2
Applicants:	12
NDAs:	15
Drug Master File Entries:	11
Finished Product Suppliers / Packagers:	9
Raw Ingredient (Bulk) Api Vendors:	78
Clinical Trials:	17
Patent Applications:	6,351
Drug Prices:	Drug price trends for PINDOLOL
What excipients (inactive ingredients) are in PINDOLOL?	PINDOLOL excipients list
DailyMed Link:	PINDOLOL at DailyMed

See drug prices for PINDOLOL

Recent Clinical Trials for PINDOLOL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Scotmann Pharmaceuticals	Phase 3
Rawalpindi Medical College	Phase 3
Quotient Sciences	Phase 1

See all PINDOLOL clinical trials

Pharmacology for PINDOLOL

Drug Class	beta-Adrenergic Blocker
Mechanism of Action	Adrenergic beta-Antagonists

Medical Subject Heading (MeSH) Categories for PINDOLOL

Adrenergic beta-Antagonists
Antihypertensive Agents
Serotonin Antagonists
Vasodilator Agents

Anatomical Therapeutic Chemical (ATC) Classes for PINDOLOL

C07AA	Beta blocking agents, non-selective
C07A	BETA BLOCKING AGENTS
C07	BETA BLOCKING AGENTS
C	Cardiovascular system

US Patents and Regulatory Information for PINDOLOL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cosette	PINDOLOL	pindolol	TABLET;ORAL	073661-002	Oct 31, 1993		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Cosette	PINDOLOL	pindolol	TABLET;ORAL	074123-001	Apr 17, 1997		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bayshore Pharms Llc	PINDOLOL	pindolol	TABLET;ORAL	211712-002	Aug 1, 2019	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for PINDOLOL

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Novartis	VISKEN	pindolol	TABLET;ORAL	018285-001	Sep 3, 1982	⤷ Sign Up	⤷ Sign Up
Novartis	VISKEN	pindolol	TABLET;ORAL	018285-002	Sep 3, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.